Join the Exploding Neoantigen-Based Therapeutics Community

As the neoantigen space continues to evolve and mature, there are emerging challenges that have exposed the complexities of creating a truly individualized therapy that can target cancers.

The Neoantigen Based Therapies Summit is the leading end-to-end meeting dedicated to delivering the promise of accurate identification, prediction and validation of neoantigens to develop highly efficacious vaccines and cell therapies.


Top 5 reasons to attend:

NeoAg numbers

Optimize novel neoantigen identification and prediction approaches with Genentech, Evaxion and Genocea to drive development of neoantigen based cancer therapeutics

NeoAg numbers (1)

Drive prediction accuracy through exploring and understanding the pros and cons of different neoantigen sources with Precision Biologics and Ervaxx

NeoAg numbers (2)

Generate stronger T cell responses and maximize immunogenicity with Gritstone Oncology and Treos Bio

NeoAg numbers (3)

Analyze and explore how neoantigens are being implemented into T cell therapies and cancer vaccines by delving into the clinical progress with Neon Therapeutics and Vaccibody

NeoAg numbers (4)

Reduce needle to needle time and overcome complex manufacturing challenges with Achilles Therapeutics, Vaximm and ISA Therapeutics

Get a Glimpse into the NeoAg Summit